Numerous law companies and legal departments have already used artificial intelligence (AI) and machine learning. The remarkable advancements in legal AI technology have some attorneys fearful that their profession may soon succumb to Silicon Valley. Artificial intelligence and legal technology will not eliminate the legal profession. By improving precision and efficiency, technology will enable growth and production. AI algorithms that have been cleverly incorporated are already changing results in corporate compliance, due diligence, contract management, and electronic discovery. Artificial intelligence has been used successfully on a limited scale in a number of sectors recently, ranging from robotic concierges in hotels to automated entertainment and mobile phones.
It has been seen that understanding and modifying the polymorphism of an already existing drug creates a scope for the better functioning of that particular drug and plays a crucial role in drug development. The best exhibit of this phenomenon is the HIV drug Ritonavir. The original component used in this drug was less soluble, but the polymorphic form of this drug proved to be less bioavailable. Countries like America, Japan, and the EU Member states generally grant the patent to the pharmaceutical companies even the drug exhibits change in minimal qualities such as stability, solubility, hygroscopicity, etc.